Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 33 (1) , 6-8
- https://doi.org/10.1016/0090-8258(89)90594-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- 1.5-5 Years of uninterrupted cis-diamminedichloroplatinum II chemotherapy for metastatic cervical cancerGynecologic Oncology, 1987
- Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1985
- Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervixGynecologic Oncology, 1984
- Cis‐diamminedichloroplatinum (II): Second line induction chemotherapy in advanced ovarian adenocarcinomaJournal of Surgical Oncology, 1983
- Cyclophosphamide, adriamycin, and platinum chemotherapy in treatment of advanced and recurrent cervical carcinomaGynecologic Oncology, 1983
- Adriamycin alone or in combination in 100 patients with carcinoma of the cervix or vaginaAmerican Journal of Obstetrics and Gynecology, 1978
- PHASE-2 STUDY OF CIS-DICHLORODIAMMINEPLATINUM(II) (NSC-119875) IN ADVANCED ADENOCARCINOMA OF OVARY1976